AirXpanders is a medical device company that has developed the AeroForm tissue expander. AeroForm is a patient controlled breast tissue expander for reconstructive surgeries such as breast reconstruction after mastectomy.

APT Pharmaceuticals is a clinical-stage company developing products to treat respiratory diseases.

Capnia is developing novel treatments for allergic rhinitis and migraine headache.

Carbylan Biosurgery is developing a next generation product combining hyaluronic acid and steroid for the treatment of osteoarthritis.

Ceptaris Therapeutics is a privately held specialty pharmaceutical company developing a product for the treatment of cutaneous T-cell lymphoma (CTCL).

Dynavax Technologies (NASDAQ: DVAX) is a clinical-stage biopharmaceutical company committed to discovering and developing novel products to prevent and treat infectious diseases.

Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of Hepatitis. Our pipeline includes preclinical NCEs from discovery as well as repurposed clinical agents to treat Hepatitis C and Hepatitis D.

Essentialis is developing a novel therapy for the treatment of dyslipidemia.

MacroGenics, Inc. is developing antibodies and vaccines in the areas of oncology, inflammation, allergy, and infectious diseases.

Medley Health is a membership practice service provider for primary care physicians and their patients.

NeoMend, Inc. is a medical device company commercializing ProGel Pleural Air Leak Sealant for lung air leaks. The company has a proprietary platform technology which seals and facilitates healing of soft tissue wounds caused by trauma or surgical procedures.

NextWave Pharmaceuticals is focused on developing innovative products for the pediatric pharmaceutical market. The company is developing and commercializing products that address many of the compliance, convenience, dosing and safety issues children and their parents face today.

Nora Therapeutics is developing novel treatments in reproductive medicine.

OncoGenex Pharmaceuticals (NASDAQ: OGXI) is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.

Palatin (NYSE: PTN) is developing melanocortin-based therapeutics. The company’s lead product, bremelanotide, is in Phase II clinical trials for female sexual dysfunction.

Rempex Pharmaceuticals is a pharmaceutical company focused on the discovery and development of new antibacterial drugs to treat multi-drug resistant bacterial pathogens.

Revance Therapeutics is a specialty pharmaceutical company focused on discovering and developing therapeutic products in the areas of aesthetic medicine and therapeutic dermatology.

Sagent Pharmaceuticals is an international specialty injectable pharmaceutical company bringing finished pharmaceutical products to the U.S. market.

Synapse BioMedical is a medical device company developing neurostimulation products. The company’s products have been approved by the FDA for patients with spinal cord injury and amyotrophic lateral sclerosis.

Tranzyme Pharma (NASDAQ:TZYM) is developing novel GI therapeutics.

TRIA Beauty is a leader in light-based therapeutic beauty systems that incorporate clinically-proven aesthetic technologies for at-home personal care regimens.

YM BioSciences Inc. (NYSE: YMI) is a pharmaceutical company advancing a diverse portfolio of promising hematology and cancer-related products at various stages of development.